As expected, the prevalence of abnormal CRP (>10 mg/L) was higher in the RCa cohort (53.8%) compared to 0% of NCa, 25% of PCa, and 16.7% of Ca cases, with statistically significant differences (P<0.001) in CRP levels between CC stages. The gene discussed is CRP; the disease is posterior cortical atrophy.